TMune Therapeutics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 2

TMune Therapeutics General Information

Description

Developer of T-cell therapies designed to treat cancer. The company's therapies help in the treatment of cancer, lymphoma, HIV, and other infectious diseases, enabling patients to get cured and lead a healthy life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2119 Delancey Street
  • Philadelphia, PA 19103
  • United States
+1 (215)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 2119 Delancey Street
  • Philadelphia, PA 19103
  • United States
+1 (215)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TMune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO 03-Jan-2012 $1.5M Completed Startup
2. Grant 01-Jan-2009 Completed Startup
1. Early Stage VC (Series A) 29-Feb-2008 $13M $13M Completed Startup
To view TMune Therapeutics’s complete valuation and funding history, request access »

TMune Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view TMune Therapeutics’s complete cap table history, request access »

TMune Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biomark Capital PE/Buyout Majority
National Institutes of Health Government
To view TMune Therapeutics’s complete investors history, request access »

TMune Therapeutics FAQs

  • When was TMune Therapeutics founded?

    TMune Therapeutics was founded in 2008.

  • Where is TMune Therapeutics headquartered?

    TMune Therapeutics is headquartered in Philadelphia, PA.

  • What industry is TMune Therapeutics in?

    TMune Therapeutics’s primary industry is Drug Discovery.

  • Is TMune Therapeutics a private or public company?

    TMune Therapeutics is a Private company.

  • What is the current valuation of TMune Therapeutics?

    The current valuation of TMune Therapeutics is .

  • What is TMune Therapeutics’s current revenue?

    The current revenue for TMune Therapeutics is .

  • How much funding has TMune Therapeutics raised over time?

    TMune Therapeutics has raised $13M.

  • Who are TMune Therapeutics’s investors?

    Biomark Capital and National Institutes of Health have invested in TMune Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »